mRNA-1403
Phase 3Active 0 views this week 0 watching
0
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Acute Gastroenteritis, Norovirus Acute Gastroenteritis
Conditions
Acute Gastroenteritis, Norovirus Acute Gastroenteritis
Trial Timeline
Sep 24, 2024 → Feb 15, 2027
NCT ID
NCT06592794About mRNA-1403
mRNA-1403 is a phase 3 stage product being developed by Moderna for Acute Gastroenteritis, Norovirus Acute Gastroenteritis. The current trial status is active. This product is registered under clinical trial identifier NCT06592794. Target conditions include Acute Gastroenteritis, Norovirus Acute Gastroenteritis.
What happened to similar drugs?
20 of 20 similar drugs in Acute Gastroenteritis, Norovirus Acute Gastroenteritis were approved
Approved (20) Terminated (4) Active (0)
✅Modification of Prasugrel based on a biological assay + prasugrel / clopidogrelDaiichi SankyoApproved
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT06592794 | Phase 3 | Active |
| NCT05992935 | Phase 2 | Active |
Competing Products
20 competing products in Acute Gastroenteritis, Norovirus Acute Gastroenteritis